Extracellular Acidity-mediated Expression of cPLA2γ Confers Resistance in Gastric Cancer Cells

Anticancer Res. 2021 Jan;41(1):211-218. doi: 10.21873/anticanres.14767.

Abstract

Background/aim: Extracellular acidity, a characteristic of solid tumors, has been proposed to be a critical factor for aggravating tumor malignancy and conferring resistance to therapeutics. Recently, acidity has been implicated in inflammatory responses, which are mediated through active lipid metabolites in various human tissues. In the present study, we investigated whether acidity can affect lipid-mediated signaling, and found that phospholipase A2 (PLA2) activity increased at acidic pH in SNU601 and AGS gastric carcinoma cell lines.

Materials and methods: To identify the PLA2 isoform that is responsible for the acidity-induced activity, we assessed mRNA levels of cPLA2 isotypes through real-time qPCR, and protein levels through immunoblot assay in cells cultured in acidic medium.

Results: It was found that acidic pH conditions markedly elevated the PLA2γ expression. A gene interference study using specific siRNA of cPLA2γ suggested that expression of cPLA2γ in acidic culture conditions may be associated with protection of cancer cells in acidic environment, as shown by cell viability and clonogenic assays. In addition, expression of cPLA2γ appeared to confer cell resistance to anticancer drugs under acidic pH conditions.

Conclusion: Acidity-induced cPLA2γ expression may exert protective effects by imparting resistance to the gastric cancer cells under acidic environment.

Keywords: Acidity; cPLA2γ; gastric cancer; resistance.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm / genetics*
  • Extracellular Space / metabolism
  • Gene Expression
  • Gene Silencing
  • Group IV Phospholipases A2 / genetics*
  • Group IV Phospholipases A2 / metabolism
  • Humans
  • Hydrogen-Ion Concentration*
  • RNA, Small Interfering
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • RNA, Small Interfering
  • PLA2G4C protein, human
  • Group IV Phospholipases A2
  • Caspase 3